{"organizations": [], "uuid": "a5f176c1ad5039db2a6b5663d69e0f9598265312", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.telegraph.co.uk", "main_image": "http://i.telegraph.co.uk/multimedia/archive/03393/71313773_File_phot_3393554k.jpg", "site_section": "http://www.telegraph.co.uk/archive/2015-08-03.html", "section_title": "News Archive - News, sport and travel archive - Telegraph", "url": "http://www.telegraph.co.uk/lifestyle/wellbeing/doctors-diary/11775331/Grounds-for-cautious-optimism-on-new-Alzheimer-drug.html", "country": "US", "title": "Grounds for 'cautious optimism' on new Alzheimer drug", "performance_score": 0, "site": "telegraph.co.uk", "participants_count": 2, "title_full": "Grounds for 'cautious optimism' on new Alzheimer drug - Telegraph", "spam_score": 0.0, "site_type": "news", "published": "2015-08-03T15:00:00.000+03:00", "replies_count": 1, "uuid": "897247354b5b39d215dad35664381e9b2a116975"}, "author": "Michael Fitzpatrick", "url": "http://www.telegraph.co.uk/lifestyle/wellbeing/doctors-diary/11775331/Grounds-for-cautious-optimism-on-new-Alzheimer-drug.html#post-0", "ord_in_thread": 0, "title": "Grounds for 'cautious optimism' on new Alzheimer drug", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "telegraph.co.uk Follow @telegraph", "external_links": [], "published": "2015-08-03T15:00:00.000+03:00", "crawled": "2015-08-03T10:29:23.010+03:00", "highlightTitle": ""}